Formycon AG
Formycon AG: Formycon appoints biotech expert Professor Johannes Buchner to the Advisory Board
DGAP-News: Formycon AG / Key word(s): Strategic Company Decision/Change of Personnel Press Release // February 1, 2016 Formycon appoints biotech expert Professor Johannes Buchner to the Advisory Board After studying Biology and receiving his PhD from the University of Regensburg in 1991, Buchner investigated new concepts in cancer treatment during his postdoctoral stay at the National Institutes of Health in Bethesda, USA. He returned to the University of Regensburg as a group leader, and since 1998 he is a Professor for Biotechnology at the Technische Universität München, Germany. His research focuses on chaperone proteins and antibodies. Buchner is a member of the German Academy of Sciences (Leopoldina) as well as the Bavarian Academy of Sciences and Humanities. He has received numerous awards for his research, including the Hans Neurath Award from the Protein Society and the Schleiden Medal awarded by Leopoldina. “I am delighted that we have been able to welcome Professor Johannes Buchner, a highly renowned professional in the field of molecular biology and antibody research. His expertise will play a significant role in our Advisory Board and will support our development work”, comments Dr. Carsten Brockmeyer, CEO of Formycon AG. In addition to Professor Buchner, the board consists of Dr. Gerhard Schaefer und Dr. Bernhard Hampl, who are both highly experienced managers and proven industry experts from the pharmaceutical sector. About Formycon: Contact: Disclaimer: This document neither constitutes an offer to sell nor a solicitation of an offer to buy or subscribe for securities of Formycon AG. No public offering of securities of Formycon AG will be made nor is a public offering intended. This document and the information contained therein may not be distributed in or into the United States of America, Canada, Australia, Japan or any other jurisdictions, in which such offer or such solicitation would be prohibited. This document does not constitute an offer for the sale of securities in the United States.
2016-02-01 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |
Language: | English | |
Company: | Formycon AG | |
Fraunhoferstraße 15 | ||
82152 Planegg-Martinsried | ||
Germany | ||
Phone: | 089 864667 100 | |
Fax: | 089 864667 110 | |
Internet: | www.formycon.com | |
ISIN: | DE000A1EWVY8 | |
WKN: | A1EWVY | |
Listed: | Regulated Unofficial Market in Berlin; Open Market (Entry Standard) in Frankfurt | |
End of News | DGAP News Service |